
DocGo (DCGO) Stock Forecast & Price Target
DocGo (DCGO) Analyst Ratings
Bulls say
DocGo Inc. is poised for financial growth, with management projecting a notable increase in revenues from its hospital segment, expected to rise from approximately $200 million in 2024 to around $250 million in 2025, largely driven by medical transportation services. The company has demonstrated strong customer retention and expansion through its logistics platform, indicating a solid market presence and potential for acquiring new clients in both existing and new markets. Additionally, the strategic shift towards the payor business, coupled with a focus on improving care quality and satisfaction, positions DocGo to effectively navigate potential revenue fluctuations and capitalize on long-term growth opportunities in value-based care arrangements.
Bears say
DocGo Inc. is experiencing a significant decline in financial performance, particularly within its Mobile Health Services segment, which reported revenues of $71.8 million—9.9% lower than estimates and a staggering 52.3% year-over-year decrease. The company's adjusted EBITDA margins are now projected to be around 5%, a substantial reduction from the previous guidance of 8% to 10%, primarily attributed to increased investments and a transition away from migrant-related revenue sources. Furthermore, the adjusted EBITDA results for the recent quarter came in at $1.1 million, significantly below the anticipated figure of $13.4 million, reflecting both lower revenues and elevated operating expenses, signaling a troubling outlook for the company's profitability and growth trajectory.
This aggregate rating is based on analysts' research of DocGo and is not a guaranteed prediction by Public.com or investment advice.
DocGo (DCGO) Analyst Forecast & Price Prediction
Start investing in DocGo (DCGO)
Order type
Buy in
Order amount
Est. shares
0 shares